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Abstract
Microarray-based comparative genome hybridisations (CGH) and genome sequencing of Clostridium difficile isolates have
shown that the genomes of this species are highly variable. To further characterize their genome variation, we employed
integration of data from CGH, genome sequencing and putative cellular pathways. Transcontinental strain comparison
using CGH data confirmed the emergence of a human-specific hypervirulent cluster. However, there was no correlation
between total toxin production and hypervirulent phenotype, indicating the possibility of involvement of additional factors
towards hypervirulence. Calculation of C. difficile core and pan genome size using CGH and sequence data estimated that
the core genome is composed of 947 to 1,033 genes and a pan genome comprised of 9,640 genes. The reconstruction,
annotation and analysis of cellular pathways revealed highly conserved pathways despite large genome variation. However,
few pathways such as tetrahydrofolate biosynthesis were found to be variable and could be contributing to adaptation
towards virulence such as antibiotic resistance.
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Introduction
Clostridium difficile is a gram-positive spore-forming anaerobic
bacterium with a wide host range [1]. In recent years it has
emerged as a major nosocomial pathogen. The complications
arising from its infection are collectively called C. difficile-associated
disease (CDAD) [2,3]. In its simplest form CDAD can lead to mild
diarrhea, but in the extremes it results in serious sequelae, toxic
megacolon, intestinal perforation, peritonitis or death [2]. Several
CDAD outbreaks in the past decade in Europe and North
America have been attributed to the emergence of hypervirulent
C. difficile strains belonging to PCR ribotype 027/pulse-field type
NAP1 (027/NAP1) which produce elevated levels of toxins A and
B, the primary virulence factors of this bacterium [4–9].
The first sequenced C. difficile genome was of a strain isolated
from a patient with pseudomembranous colitis in Zurich,
Switzerland [10]. This genome contains a large number of mobile
genetic elements and very low genome conservation when
compared to other C. difficile strains and also to other members
of Clostridia. A microarray-based comparative genome hybridiza-
tion (CGH) of this strain against 8 other C. difficile strains showed
that the up to 61% of the total coding sequences (CDS) were
absent from at least one strain tested [10]. A subsequent CGH
comparison of 75 C. difficile strains revealed that only 19.7% genes
were shared by all strains studied [11]. In our recent CGH analysis
of a similar number of strains showed that the core genome of this
species could be as low as 16% [12]. The absent/divergent genes
in the tested strains were distributed across the entire C. difficile
genome and across all gene functional categories [12]. It is
surprising that the ‘‘core gene set’’ containing conserved genes in
all tested C. difficile strains is unusually low and to our knowledge it
is probably the smallest core genome reported for any bacterial
species so far. For example, in other bacterial species with a large
amount of genome variation such as Helicobacter pylori and
Campylobacter jejuni, the core genomes were reported to be 72.5%
and 59.2% of their total genomes, respectively [13]. Recently,
genome sequencing of additional C. difficile strains further
confirmed the large-scale genome variation in this species
[14,15]. Considering the ultra low genome conservation in C.
difficile, in this study, we conducted a detailed analysis of the
genome variation by integrating microarray CGH data, compar-
ative genome sequencing and genome pathway data. First we
compared 167 C. difficile strains using CGH data and the results
were then corroborated using comparative genome sequencing of
4 divergent strains from the CGH-analyzed strains and also by
comparing these genomes with 11 other C. difficile genomes.
Finally the impact of the genome variation on C. difficile pathways
was analyzed by pathway reconstruction and annotation using
high-throughput experimental data as well as overlaying CGH
data onto the curated pathways.
Results and Discussion
Analysis of genome variation using CGH data
The microarray dataset in this study comprised CGH
comparison of 167 strains in total from three different sources.
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human, bovine, canine and food origin (Table S1) using our
C. difficile spotted arrays (Gene expression omnibus (GEO)
platform: GPL6118). Although CGH analysis of isolates from
human and bovine origins has been carried out previously, this
study is the first CGH comparison of food and canine C. difficile
isolates. The other sources of the data are meta-analyses of CGH
data from Stabler et al study [11] and a former study by our group
[12]. Since these two studies utilized PCR-based and 70-mer
oligonucleotide spotted array platforms, we therefore evaluated the
comparability of both datasets before combining them. Using
GACK transformed CGH data (Table S2), we devised an index
called Locus Plasticity Index (LPI). The LPI value for a CDS
represents a numerical value of the degree of each gene’s variation.
Under this scheme, when a gene is present in all strains in the
comparison, it would receive a value of +1.0 and when the gene is
absent from all strains except the reference strain, the value will
be 21.0. The range in between will be indication of degree
of divergence. A projection of LPI values for all CDS in C. difficile
630 calculated separately and jointly from these two platforms
is given in Figure 1. The results revealed that both platforms
were highly comparable with a high correlation coefficient of 0.88
(Table S3). Consistent with the previous findings, the variation
was distributed across the entire C. difficile genome. The regions
with negative LPI values corresponded to those of mobile
genetic elements. Deletions in several loci have been
proposed to be specifically associated with hypervirulent strains
[11]. However, a closer examination of our dataset showed that
this is not always the case. For example, the loci of CD0719-
CD0724 were intact in some of the 027/NAP1 strains in our
collection. The genome of one of these strains, QCD-32g58, has
been sequenced and these results also support the microarray data.
Two studies of CGH of C. difficile yielded slightly different
predictions of the core genome size [11,12]. Here, the genes with
high LPI values represent the core genes or genes with limited
sequence variation.
Although there are a total of 3,971 CDS in C. difficile 630, we
could only map 3,574 CDS in our dataset due to microarray
platform differences. Of these, 151 CDS had an LPI value of +1.0.
The genes with LPI values in the range of 0.95 to 0.99 received the
lower values because 1–3 strains in either of the datasets classified
these loci as divergent. This discrepancy arises due to the
difference in microarray platform used. Stabler’s data were based
on PCR product arrays which although provided higher signals as
full CDS were printed, but were prone to cross-hybridization.
Microarrays used by our group were 70mer-based spotted array
that produced more stringent results. However when the probes
representing a CDS span a hyper-variable region of the gene, the
signal could be reduced or lost and the CDS could be classified as
being absent/divergent. This reflected in the core gene estimations
in the previous analysis. According to Stabler et al the C. difficile
core genome is 19.7% of the total 630 genome [11] while Janvilisri
et al estimated it to be 16% of the total CDS [12]. Both estimates
heavily lean towards eliminating false positives. For example,
slpA gene encoding a major cell surface protein that forms a
paracrystalline array in C. difficile contains a conserved region and
a variable region [16–18]. This gene was classified as absent
in both the previous analysis. Similarly it has been pointed out
that due to several point mutations in tcdB, toxin B-positive strains
were marked as negative as this is beyond the detection specificity
of microarrays [11]. In the ternary classification scheme such
genes are not included in the core gene set and the LPI index
scheme would be a better representation of variability in such
instances.
Transcontinental strain comparison
For transcontinental strain comparison, using the GACK
transformed data; we constructed an hierarchical clustering
(HCL) support tree (Figure 2). Evidently, each cluster contained
C. difficile isolates from different host origins, except one (marked as
a red branch in Figure 2) that was entirely composed of human
isolates. Interestingly, all strains in this cluster belonged to the
hypervirulent (HY) clade in Stabler et al. [11] and the Group II
cluster in Janvilisri et al. [12] studies. Except for one strain (BI-14)
from Stabler’s dataset [11], the strains from both of these previous
reports did not mix in this cluster and formed two close sub-
clusters under a single branch. However, we considered strains
within this major cluster as HY strains because of (i) the similarity
between the strains from the Group II in Janvilisri et al. study [12]
and the HY clade in Stabler et al. study [11]; (ii) the association
between the outbreaks and the 027/NAP1 phenotype of certain
strains in this cluster (#5098, 6088, 32g58, 4102 and 6071); (iii)
the clustering of the HY outlier BI-14 strain in Stabler’s study [11]
with the Group II strains from Janvilisri et al. study [12]; and (iv)
the clustering of the human strain 8694 (originally designated as
CIP 107932) that was isolated in 1984 from a patient with
pseudomembranous colitis from Reims, France, with the HY clade
strains.
To analyze the relationship between total toxin production and
clustering pattern, we measured the total toxin production in the
strains from our collection using ELISA. The results showed that
there was no correlation between clustering pattern and total toxin
production (Figure 2). The highest amount of toxin was produced
by the strain #6432. This strain belonged to toxinotype XIV/XV
and had an 18 bp deletion in tcdC gene [12]. The strain #8694
(CIP 107932) was the second highest toxin-producing strain.
Consistently, this strain has been shown to produce more toxin
than several 027/NAP1 strains [
19]. It has also been shown that
the 8694 (CIP 107932) strain exhibits a lower sporulation rate
compared to other strains [19]. Such strains with a high level of
toxin production but a low level of sporulation usually have a poor
transmission rate. This may explain the reason why this strain is
not reported in recent outbreaks. The third highest toxin
production level was found in an equine isolate (#115). This
strain however was not included in the HY cluster. Our results
showed that certain non-027/NAP1 strains exhibited comparable
or higher toxin levels than 027/NAP1 strains, pointing towards the
possibility of additional factors responsible for the HY phenotype.
Although hypervirulence in C. difficile has often been linked to
elevated levels of toxin production [9], involvement of other
factors such as an increase in sporulation have also been suggested
[19]. Consistent with our results, a study of 164 C. difficile strains
with different PCR ribotypes isolated from patients with different
severities of CDAD revealed that there was no correlation between
the levels of toxin measured in vitro and fecal samples for the
corresponding C. difficile isolates or between the PCR ribotypes
and disease severity [20].
The isolates for which the CGH was conducted exclusively in
this study were found to be clustering in different parts of the HCL
support tree. The prevalence of C. difficile isolated from both farm
and companion animals is increasing recently [
21]. C. difficile
transmission between animals and human is often suspected as the
reason for widespread CDAD incidences [22]. Hence this
clustering pattern particularly for the dog isolates is not surprising.
Interestingly, one of the food isolates (#6430) was grouped in the
HY cluster, suggesting the possibility of food-borne transmission of
HY C. difficile. The other food isolates were scattered in the HCL
tree.
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isolates
Based on CGH comparison with the reference genome C.
difficile 630, we selected four isolates with high levels of CDS
divergence for sequencing. These included two human (#6466
and 6503), one equine (#6407) and one bovine (#6534) isolates.
The sequencing read parameters for the above genomes is given in
Table 1. Comparison between these sequenced genomes with
other C. difficile genomes available in NCBI database showed that
the median number of genes for all strains to be 4,047. The
number of unique genes (i.e. genes that have no homology in any
other genomes compared here) in four strains sequenced in this
study was much higher than other sequenced genomes (Table 2).
Previous CGH analysis of these four strains showed that ,700
CDS in these strains were divergent [12]. Hence the discovery of
higher number of unique genes in these genomes supports the
detection of large number of divergent CDS in CGH comparisons.
Since the median number of CDS across the strains is close to the
number of CDS in the reference strain, it can be assumed that
despite massive variation, the genome size is stable. OrthoMCL
program was used to identify orthologues that were shared across
all genomes (core genes), orthologues shared between two or more
genomes (shared genes) and genes unique to only one genome
(unique genes). There were a total of 7,846 genes for all 15 strains.
Of these, 1,026 were present across all genomes, 3,864 were
shared and 2,956 were singletons. The pairwise comparisons
between all 15 genomes are summarized Figure 3. A fasta file
containing all the CDS from all strains compared in this study is
available in Dataset S1 and S2.
Prediction of core and pan genome size
The core and pan genome size was estimated using both
microarray and genome sequence data. The accuracy of these
estimates depends on the nature of the strains sampled and the
sample size, where a larger dataset containing isolates from various
hosts from different geographical locations would yield a better
prediction. The GACK transformed microarray dataset (Table
S2), was used to fit exponential regression function [23]. As
expected, the number of core genes reduced dramatically with
initial addition of strains in the random sampling, but stabilized
with progressive sampling and reached a plateau. The results
indicated a core genome size of about 947 genes (23.7% of the
total CDS) (Figure 4A).
In order to estimate the core and pan genome size using
genome sequence data, we followed a method similar to the one
described by Tettelin et al. [23]. We sequentially added strains in
random order and parsed the OrthoMCL output to calculate (a)
the number of genes that have homologous genes in all strains and
(b) the number of genes that are ‘‘new’’ to each strain, i.e. those
that have no homology in any of the strains. We repeated this for
10,000 random permutations of strain order. As pointed out in a
recent review [24], the choice of cut-off points to define the core,
Figure 1. Comparison of CGH data from different microarray platforms and projection of CDS variability across C. difficile genome.
From outside to inside: Ring 1 (Solid line). Molecular clock drawn using C. difficile 630 genome. Ring 2 (Blue). LPI calculated using strains from Janvilisri
et al. data. Ring 3 (Green). LPI calculated using Stabler et al data. Ring 4 (Orange). LPI calculated using combined dataset (Table S3).
doi:10.1371/journal.pone.0015147.g001
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greatly influence these projections. Hence we used low, medium
and high BLAST-P E-values to make the comparisons in
OrthoMCL analysis. However, all three parameters returned
similar gene estimates. To avoid the effect of differences in the
genome annotation, we also re-annotated previously sequenced
genomes using the JCVI annotation pipeline. The genes with
homology in all strains constitute the ‘‘core genome’’ of C. difficile,
and a plot of the number of core genes as a function of strain
number (n) is shown in Figure 4B. It was observed that the core
genome consists of 1,033 genes at n=15. The difference in the
estimated core genome size could be due to the difference in the
number of CDS in microarray and sequence data. However, the
number of core genes in both predictions is higher when compared
to the previous reports [11,12]. A plot of the number of new genes
per sequenced strain (strain-specific genes) as a function of the
number of strains (n) is shown in Figure 4C. We found that the
number of strain-specific genes was ,286 (n=15) with a
decreasing trend if the n is higher. Using a cubic function fit in
the extrapolation, we found that the number of new genes tended
Figure 2. Support tree constructed from CGH data of a total of 167 C. difficile isolates. Solid circles and triangles represent strains from our
collection and Stabler et al. respectively. Open circles represent sequenced strains. Numbers next to these symbols are strain abbreviation from
Figure S1. Color legends for host origin are given at the center of the figure. Hypervirulent clade is marked as a red branch. Strains sequenced in this
study are marked as green branch. The diamonds in the outermost ring represent the total toxin estimates of strains from our collection. The toxin
intensity scale normalized to C. difficile 630 is given at the bottom of the figure.
doi:10.1371/journal.pone.0015147.g002
Low Genome Conservation in C. difficile
PLoS ONE | www.plosone.org 4 December 2010 | Volume 5 | Issue 12 | e15147toward zero at n=26. This indicated that roughly 26 strains were
required to capture the entire pan-genome of C difficile. We also
found that the size of pan genome increased sharply with initial
addition of genomes, but seemed to reach a plateau at ,9,640
genes (Figure 4D).
Although the new core genome projection is higher than the
previous estimates [11,12], it is still much lower than the core
genome estimates of other bacterial species. For example, when
Tettelin et al first introduced the concept of core and pan genome,
they estimated the core genome in Streptococcus agalactiae to be 80%
of the genome [23]. In S. pneumoniae, this is estimated as low as
46.5% of the genome [25]. The naturally competent H. pylori is
projected to have a core genome of 72.5% of the total genome
[13] and in Campylobacter jejuni it is estimated to be 59.2% [26]. The
pan genome estimate of C. difficile (9,640 genes) derived from
sequence data extrapolation, showed that many more strains are
needed to be sequenced to reveal the complete species genome
pool. Since the non-epidemic animal and human isolates
contained more unique genes than other epidemic strains, we
speculate that the ‘‘accessory gene pool’’ available in these non-
epidemic strains is being exchanged between strains, thereby
enabling adaptive responses to new niches.
Prediction and curation of pathways in C. difficile
In the light of the large-scale genome variation, we analyzed the
impact of this variation in the cellular pathways and biochemical
networks. Since the perturbation in basic cellular machinery can
make cell unviable, reconstruction of cellular pathways can
complement sequence-based genome analysis. When such recon-
structions are combined with experimental data including
transcriptional profiling and proteome sequencing, it cannot only
provide a quality control of the assumptions made from the
sequence data but also can identify missing enzymes and potential
targets for combination therapy [27,28]. Pathologic program [29]
in Pathway tools package [30] was used to construct the cellular
pathways of C. difficile 630 from its genome sequence. Metacyc was
used as the reference database and pathway hole filler in
Pathologic was used to infer missing links in pathways [31]. The
pathologic program in Pathway tools package is reported to have
accuracy comparable to that of an expert biochemist, but exceeds
the expert analysis in its comprehensiveness [32]. This automated
reconstruction returned a total of 866 enzymes, 1,038 reactions,
828 compounds and 191 pathways. To ascertain our predictions,
we then used microarray expression and proteome sequencing
data onto the predicted pathways. First, we used the microarray
dataset derived from Emerson et al. study [33] in which the
transcriptional profile of C. difficile was analyzed after exposure to
antibiotics, pH shift, temperature shift and aerobic shock. When a
combined list of significantly differentially expressed (DE) genes
following the exposure to antibiotics including amoxicillin,
clindamycin and metrinadazole was overlaid onto cellular
pathways, it was found that most DE genes were involved in the
reactions of cell structure biosynthesis pathways (peptodoglycan
biosysnthesis I, II & III, teichoic acid biosynthesis and UDP-N-
acetyle-D-glucosamine biosynthesis I). The fact that the antibiotics
such as amoxicillin disrupt the cell wall biosynthesis supports our
strategy of using high-throughput data for pathway curation.
Using the combination of all conditions in the Emerson et al.
dataset, a total of 168 pathways were mapped (Table 3). Next, we
were able to map a total of 62 pathways using the dataset from a
study by our group in which C. difficile 630 was used to infect Caco-
2 cells up to 120 min post-infection [
34]. Some of these were
overlapping with pathways mapped from previous dataset but
some were unique to this dataset. Finally, we used data from C.
difficile membrane protein sequencing [35] and spore proteome
sequences [36] to ascertain the predicted pathways. Using the
spore protein data, we were able to map 81 pathways whereas
membrane protein sequences were mapped onto 32 pathways. All
the pathways mapped using membrane protein data were already
mapped by spore protein data. When all pathway mappings were
converged, we were able to ascertain the presence of 398 enzymes,
584 reactions, 598 compounds and 152 pathways (Table 3). Since
several pathways were mapped to more than one dataset, these
pathways could be ascertained with high confidence. A summary
of the mapped pathways from all datasets is given in Figure S1,
and the list of the genes in all datasets used for this analysis is given
in Table S4. Similar approaches have been employed in the
pathway reconstruction of H. pylori, Vibrio cholerae and Leishmania
major [32,37,38]. Since we integrated multiple independent
datasets into the pathway verification, our results can be viewed
with high confidence.
Analysis of pathway variation reveals adaptations
towards increased virulence
To further characterize the pathways in C. difficile, we also
analyzed the variation in these pathways by overlaying LPI index
for each gene. The results revealed that despite the massive
Table 1. Summary of sequencing parameters for C. difficile
genomes sequenced in this study.
Strain
Total number
of reads
Total number
of bases
Average read
length (bp)
6503 401956 90156026 224.3
6466 234489 50759251 216.5
6407 102112 19265037 188.7
6534 182210 38828208 213.1
doi:10.1371/journal.pone.0015147.t001
Table 2. Summary of C. difficile genomes compared in this
study.
Strain
Host
origin
Genome
size (bp) Genes
Genbank
Accession
630 Human 4290252 3971 AM180355
QCD-97b34 Human 4061547 3748 ABHF00000000
ATCC 43255 Human 3919385 3959 ABKJ00000000
CIP 107932 Human 4056252 3686 ABKK00000000
QCD-23m63 Human 4198222 3611 ABKL00000000
QCD-63q42 Human 4442974 4243 ABHD00000000
QCD-76w55 Human 4395390 4094 ABHE00000000
QCD-37x79 Human 4331780 4082 ABHG00000000
QCD-32g58 Human 3919067 4071 AAML00000000
R20291 Human 4073348 3567 NC_013316
CD196 Human 4006976 3595 NC_013315
6466 Human 3914179 4601 ADDE00000000
6407 Equine 3548389 7328 ADEH00000000
6503 Human 4211360 4024 ADEI00000000
6534 Bovine 4411772 5609 ADEJ00000000
doi:10.1371/journal.pone.0015147.t002
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conserved. Variation in certain pathways was due to the variability
of less than a dozen of enzymes that were part of multiple
pathways (Figure 5). The most notable variation was in the
biosynthesis pathways of cofactors, prosthetic groups, electron
carriers as well as nucleotides and nucleosides. Examples include (i)
folD (LPI =0.6) encoding for the bifunctional protein, a key
component of tetrahydrofolate biosynthesis pathway; (ii) malY (LPI
=0.5) encoding a bifunctional protein in the methionine
biosynthesis pathway which is coupled with tetrahydrofolate
synthesis; (iii) nrdE (LPI =0.78) encoding a component of
ribonucleoside reductase alpha chain; (iv) CD0244 (LPI =
20.45) encoding a glycerophosphotransferase in teichoic acid
biosynthesis pathway and (v) erm1b (LPI =20.45) encoding a
protein involved in antibiotic resistance. Variation in other
pathway components with disposable functions was also found.
Interestingly, when the product of CD0244 was searched against
other NCBI bacterial genomes using BLAST-P, the best
bidirectional hit was against the gene HMPREF0542_1838
(hypothetical protein) from Lactobacillus ruminis E194e ATCC
25644, indicating that this gene might have been acquired by
horizontal transfer. It is surprising to find the variation in
tetrahydrofolate biosynthesis indicated by the low LPI values of
folD and malY as this pathway is conserved in all bacteria [39].
Figure 3. Pairwise genome sequence comparisons. Each of the genome is compared against 14 other genomes. Color-coding designates the
following four comparisons between pairs of genomes. Grey; the total number of genes in each pair, green; the number of shared genes in each pair,
yellow; the number of genes that are different between the pair, and purple; the number of conserved genes between the pair but absent in all other
genomes.
doi:10.1371/journal.pone.0015147.g003
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of biosynthetic processes, including the formation of methionine,
purines and thymine. Furthermore, tetrahydrofolate can also act as
an acceptor of one-carbon units in degradative reactions [39].
Although all organisms require folate, methods for obtaining them
differ between prokaryotes and higher organisms. While mammals
possess an active transport system, utilizing membrane-associated
folate transport proteins [40], folates must be synthesized de novo
through the folate biosynthetic pathway in plants and most
microorganisms. Hence, folate biosynthesis pathway is usually a
target of many antibiotics including sulfonamide and trimetho-
prims. To exclude the possibility that the low LPI values of these
could have resulted from the loss of signal in microarray
hybridization due to sequence variability in the gene, we examined
the OthoMCL output of all sequenced genomes in this analysis. We
found the presence of folD in all strains with variation in the
nucleotide sequence in some of these genomes.
Genes like dnaN, dnaH, gyrB and recA that are associated with
DNA replication, recombination and repair pathways were also
found to have relatively low LPIs. Fluoroquinolone (FQ)
antibiotics such as ciprofloxacin interfere with bacterial growth
by causing DNA damage [41,42]. Surveys now show an alarming
pattern of resistance to the majority of FQs currently used in
hospitals and outpatient settings with many strains having
mutations in gyrA [43]. It has been also suggested that
ciprofloxacin may induce repair pathways that involve RecA-
ssDNA filament formation; the drug itself may act to induce the
mutations that confer resistance [44]. Hence the sequence
variation in genes like gyrB and recA could be the result of FQ
therapy to treat C. difficile infection.
Figure 4. Estimation of core and pan-genome size. The GACK transformed microarray data (Table S2), was used to fit exponential regression
function [27] (A) For calculation of core genome size using sequence data, OrthoMCL output after comparing 15 genomes was parsed using custom
PERL script and genome sequences were added in random order with 10,000 permutations (B). A plot of the number of new genes per sequenced
strain (strain-specific genes) as a function of the number of strains (n) is shown in 4(C). Pan-genome estimate using a cubic function fit is shown in
4(D).
doi:10.1371/journal.pone.0015147.g004
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by comparing the presence of these genes in all sequenced
genomes. The comparisons showed the presence of the genes with
high LPI values in all sequenced genomes, indicating that the
pathway preservation indicated by microarray data also reflected
in the sequence level data. Since some sequence variation was
found for genes like gyrB and recA in sequenced genomes, the
distribution of all the genes constituting homologous recombina-
tion, mismatch repair, nucleotide excision repair, base excision
repair and DNA replication machinery was examined across all
sequenced genomes. The results showed that all of these pathways
and most of the genes constituting these pathways were conserved
across the genomes (Table S5). Although the link between
antibiotic exposure and bacterial sequence variation in genes such
as gyrB and recA has been established, evidence for the role of
sequence variation in genes such as dnaN and dnaH antibiotic
treatment is scanty. It has been shown that in E. coli, ciprofloxacin
induced damage is countered by induction of nucleotide excision
repair (NER), homologous recombination (HR) and SOS response
[42]. Hence it is possible that the variation in dnaN in C. difficile
could be the result of a recombination-mediated mechanism to
counteract the action of antibiotic like ciprofloxacin. However,
further investigations are required to clarify this probability.
Materials and Methods
Genomic DNA extraction, microarray hybridization, data
analysis and support tree construction
Genomic DNA extraction, DNA labeling and microarray CGH
of food, dog and bovine isolates against C. difficile 630 DNA was
carried out using a custom array (GEO platform ID GPL6118) as
described previously [12]. CGH data from this study were
submitted to GEO (accession number GSE19343). CGH data of
73 C. difficile isolates hybridized against C. difficile 630 DNA was
downloaded from GEO Series GSE9693 [12]. Normalized CGH
data for 75 C. difficile isolates from Stabler et al [11] was
downloaded from ArrayExpress (accession number E-BUGS-41).
The complete detail of all strains used in this analysis is given in
Table S1. To place the reference strain C. difficile 630 in
comparison tree, self-CGH was performed. After normalization,
the genes in the whole dataset (167 strains in total) were classified
as present, absent or divergent using 100% EPP cutoff using
GACK algorithm [45]. For transcontinental strain comparison, a
support tree was constructed using HCL support tree algorithm in
Mev [46]. Trees were re-sampled by jackknifing with 1,000
iterations with Pearson correlation as the distance matric and
complete linkage rule. The resulting tree was exported in Newic
format and modified in MEGA 4.0 [47].
Calculation of locus plasticity index
GACK algorithm does not give information on the degree of
divergence of individual genes in the divergent category [45]. To
numerically represent the level of divergence in each CDS, we
devised a new index named Locus Plasticity Index (LPI) from
GACK transformed data; calculated as
Locus Plasticity IndexLPI~
NpzNa
N

Where, Np= number of present loci, Na= number of absent
loci and N= number of present, absent and divergent loci.
Measurement of total toxin production
Strains were stocked in 280uC and were inoculated into
modified BHI broth. BHI broth was prepared from Difco
TM Brain
Heart Infusion. For reducing the medium, 20 ml/L of OxyraseH
for broth was added and the medium was incubated at 37uCi na n
anaerobic chamber overnight. To ensure equilibration of all
strains in the growth medium, all strains were sub-cultured three
times. 1 ml was withdrawn at 48 h post-inoculation from the third
culture and was then passed through 0.22-mm membrane. 200 ml
of the filtrate was then used for total toxin quantification using
Premier Toxin A&B ELISA kit following the manufacture’s
protocol (Meridian Bioscience Inc. Ohio). To normalize any cell
density differences in between strains growth and toxin levels, each
strains OD600 was measured and ELISA intensity values were
divided by corresponding OD600 values. Two biological replicates
were performed and the means of ELISA intensity were taken as
the final toxin level. For comparative analysis, ELISA intensities of
all strains were divided by the reference strain C. difficile 630
ELISA intensity.
Pathway reconstruction, curation and analysis of
pathway variation
For reconstruction of C. difficile pathways, the complete genome
sequence of the reference strain C. difficile 630 was downloaded
from Genbank (accession number AM180355). Using Pathologic
tool from Pathway tools software [30,48], the complete cellular
pathways were predicted. Pathway hole filler program [29] was
used to fill the missing links or holes in the predicted pathways.
This program utilizes the BLAST searches of a set of sequences
encoding the required activity in other genomes to identify
candidate proteins in the genome of interest, in addition to
genomic context (such as the candidate enzyme being in the same
operon as another gene in the pathway) to determine the
probability that a candidate enzyme has the required function
[29]. Automatically predicted pathways were then curated
manually using microarray expression and proteome data. A list
of genes in C. difficile 630 whose expression changed significantly in
different transcriptional conditions was obtained from Emerson
et al study [33]. A second set of genes that were detected to be
active at protein level was derived from C. difficile 630 membrane
proteome analysis conducted by Wright et al [35]. Finally genes
that were coding for C. difficile spore were obtained from spore
proteome sequencing conducted by Lawley et al [36]. A pathway
was deemed present when any gene from the above datasets
mapped to that pathway. Cellular Omics viewer program [48] in
Pathway tools was used for overlaying the LPI values for all C.
difficile CDS on to the curated pathways.
Table 3. Summary of pathway prediction and evidence
support.
Condition Pathways Enzymes Reactions Compounds
Total predicted 191 866 1038 828
pH 18 80 119 189
Temperature 62 252 307 368
Antibiotic 88 312 425 471
Caco-2 cell infection 62 265 299 344
Spore protein 81 289 378 423
Membrane proteins 32 121 133 167
Combination of all
evidences
152 398 584 598
doi:10.1371/journal.pone.0015147.t003
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Based on the CGH results, we selected four strains with large
number of variant CDS (strains 6407, 6466, 6503 and 6534) for
genome sequencing. Genomic DNA of these strains was
sequenced by 454 Life Sciences GS-20 sequencer using standard
protocols [49]. Using non-paired end sequencing chemistry,
strains were sequenced up to a depth of 15x and assembled de
novo by the 454 Newbler assembler. Contigs were ordered and
oriented based on their alignment to the reference genome C.
difficile 630 using NUCMER. Contigs thus ordered and those
matching to reference sequence were joined together into a
pseudochromosome, and non-matching contigs were added at the
end in random order. A linker sequence (NNNNN CAT TCC
ATT CAT TAA TTA ATT AAT GAA TGA ATG NNNNN)
that provided start and stop codons in all six reading frames
permitting the identification of genes that extend past the ends was
used to join the contigs. The pseudochromosome for each strain
was submitted to the J. Craig Venter Institute (JCVI) annotation
service, where it was run through JCVI’s prokaryotic annotation
pipeline. Included in the pipeline is gene finding with Glimmer,
Blast-extend-repraze (BER) searches, HMM searches, TMHMM
searches, SignalP predictions, and automatic annotations from
AutoAnnotate. All of this information is stored in a MySQL
database and associated files which were downloaded to our site.
The other 11 genomes included in this analysis were downloaded
from NCBI, thus constituting a total of 15 strains in the
comparative analysis (Table 2). Using coding sequences from
each strain, orthologs were determined and clustered using
OrthoMCL[50]. OrthoMCL was run with a BLAST E-value
cut-off of 1e-5, and an inflation parameter of 1.5. Custom PERL
scripts were used to parse the OrthoMCL output for cluster
information and pair wise strain comparisons. Core and pan-
genome size was estimated following the methods described by
Tettelin et al [23]. Core genome size was calculated using both
microarray data and OrthoMCL output and pan-genome size was
calculated using OrthoMCL output alone.
Supporting Information
Table S1 A list of strains used in CGH comparisons.
(XLS)
Table S2 A list containing GACK transformed micro-
array data for all strains.
(XLS)
Table S3 A list containing LPI values for all genes in C.
difficile.
(XLS)
Table S4 A list of DE genes from all microarray and
proteome sequencing that were used for annotating C.
difficile pathways.
(XLS)
Table S5 A list containing LPI of genes involved in
recombination, mismatch repair, nucleotide excision
repair, base excision repair and DNA replication
machinery of C. difficile.
(XLS)
Dataset S1 A text file containing all gene sequences in
FASTA format from all 15 strains used for genome
comparisons.
(RAR)
Dataset S2 A text file containing all gene sequences in
FASTA format from all 15 strains used for genome
comparisons (continuation of Dataset S1).
(RAR)
Figure 5. Analysis of pathway variation. LPI values from combined microarray CGH data were overlaid on C. difficile 630 pathways. The color
scale on the right side of the figure indicates LPI range. Red indicates no variation and yellow indicates maximum variation. Key variable reactions are
indicated by numbers on the pathways and their LPI values are given as bar graphs on the right bottom of the figure.
doi:10.1371/journal.pone.0015147.g005
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